Green Cross LabCell Receives Approval for Phase 1 Clinical Trial of Psoriasis Stem Cell Therapy Candidate
[Asia Economy Reporter Chunhee Lee] GC Green Cross LabCell's phase 1 clinical trial plan for the stem cell therapy candidate CT303 for plaque psoriasis has been approved by the Ministry of Food and Drug Safety.
Green Cross LabCell announced on the 19th that it received approval from the Ministry of Food and Drug Safety for a phase 1 clinical trial administering CT303 to patients with plaque psoriasis.
Green Cross LabCell plans to evaluate the safety and tolerability of the drug by dividing 24 patients with moderate to severe plaque psoriasis into two groups of 12 each: a single-dose group and a repeated-dose group. The clinical trial will be conducted at three domestic hospitals: Seoul National University Hospital, Pusan National University Hospital, and CHA University Bundang CHA Hospital.
CT303 is an allogeneic tonsil-derived mesenchymal stem cell prepared using tonsil tissue collected from healthy donors under the age of 10. The company expects CT303 to provide longer-term therapeutic effects for psoriasis patients through a mechanism that regulates excessive immune responses.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
Psoriasis is a chronic skin disease in which skin keratinocytes grow too quickly, causing the stratum corneum to become abnormally thickened. The exact cause has not yet been identified. However, it is known as a type of autoimmune disease in which the immune system mistakenly attacks the skin as if it were an external substance.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
